Welch Allyn and Gentag Wearable Medical Device Deal Announced

Welch Allyn and Gentag Wearable Medical Device Deal Announced

Skaneateles, NY, and Washington, DC, October 28, 2014 — Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and Gentag, Inc., a pioneer in disposable biosensors that can be read with near field communication (NFC) devices, announced today that they have entered into a strategic development agreement. Under the terms of the agreement, Welch Allyn and Gentag will bring to market near field communication technology for medical devices and sensors.

The partnership with Gentag enables Welch Allyn to continue providing innovative solutions in medical settings, and NFC will allow the extension of these technologies for remote patient monitoring worldwide.

“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Welch Allyn President and CEO, Stephen Meyer.

With Gentag’s NFC technology, it becomes possible to integrate ultrathin battery-less wireless sensors into various medical diagnostic applications. Sending patient measurement data wirelessly via near field communications will open up significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record.

“We are delighted by the partnership with Welch Allyn,” said Gentag CEO, John Peeters. “Welch Allyn has the knowledge, expertise and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings. By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”

About Welch Allyn, Inc.

Since 1915 Welch Allyn has brought a unique perspective to developing diagnostic solutions by combining pragmatic knowledge with a visionary spirit of innovation and ongoing improvement. As a leading global manufacturer of physical examination instruments and accessories and EMR-connected vital signs and cardiac monitoring solutions, the company has a steadfast commitment to delivering superlative medical products, services and solutions that help healthcare professionals provide better care for their patients. Welch Allyn is headquartered in Skaneateles Falls, N.Y. (USA) and employs more than 2,600 people in 26 different countries. Visit www.welchallyn.com for more information. Like us on Facebook and follow us on Twitter.

About Gentag

Gentag, Inc. is pioneering the use of disposable, ultrathin wearable and immunoassay biosensors that can be read with NFC-enabled devices, which will make healthcare and consumer diagnostics more affordable and accessible to all worldwide. The company’s groundbreaking work will revolutionize not only medical applications, but also location-based services and the detection of environmental threats in homes and workplaces. Gentag’s first wireless sensor network patent was filed in 1997. All Gentag NFC patents are held by Altivera, LLC, a Maryland company operated by Gentag and owned by its shareholders. Gentag’s powerful IP and partnerships are at work for a smarter, more connected world. For more information, visit www.gentag.com and follow Gentag on Twitter (@gentagInc).